Lazar, Harold L <br/><br/>
Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass.  [electronic resource] 

 -  Circulation  Sep 2004 
 - II274-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.CIR.0000138315.99788.eb  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Cardiac Surgical Procedures--mortality<br/>Cardiopulmonary Bypass--adverse effects<br/>Complement Activation--drug effects<br/>Complement C3a--biosynthesis<br/>Complement Membrane Attack Complex--biosynthesis<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Infections--epidemiology<br/>Injections, Intravenous<br/>Intra-Aortic Balloon Pumping--statistics & numerical data<br/>Length of Stay--statistics & numerical data<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--diagnosis<br/>Myocardial Ischemia--etiology<br/>Prospective Studies<br/>Receptors, Complement--administration & dosage<br/>Sex Factors<br/>Solubility<br/>Treatment Outcome